Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126082971 | 12608297 | 1 | I | 20111026 | 20120927 | 20160729 | 20160729 | EXP | JP-009507513-1305JPN007837 | MERCK | 36.00 | YR | F | Y | 50.00000 | KG | 20160729 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126082971 | 12608297 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 75 MG/M2, QD | 10925 | MG/M2 | 21029 | 75 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 2 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 75 MG/M2, QD | 10925 | MG/M2 | 21029 | 75 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 3 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 4 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 200 MG/M2, QD | 10925 | MG/M2 | 21029 | 200 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 5 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 200 MG/M2, QD | 10925 | MG/M2 | 21029 | 200 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 6 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 200 MG/M2, QD | 10925 | MG/M2 | 21029 | 200 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 7 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 200 MG/M2, QD | 10925 | MG/M2 | 21029 | 200 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 8 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 200 MG/M2, QD | 10925 | MG/M2 | 21029 | 200 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 9 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 10 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 11 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 12 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 13 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 14 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 15 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 16 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 17 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 18 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 19 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 20 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 21 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | 150 MG/M2, QD | 10925 | MG/M2 | 21029 | 150 | MG/M**2 | CAPSULE | QD | ||||
126082971 | 12608297 | 22 | SS | E KEPPRA | LEVETIRACETAM | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 23 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | TABLET | ||||||||
126082971 | 12608297 | 24 | C | BAKTAR | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | POWDER FOR ORAL SOLUTION | |||||||||
126082971 | 12608297 | 25 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 26 | C | EMEND | APREPITANT | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | CAPSULE | |||||||||
126082971 | 12608297 | 27 | C | NASEA | RAMOSETRON HYDROCHLORIDE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 28 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 29 | C | MAGLAX (magnesium oxide) | MAGNESIUM OXIDE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 30 | C | MYSTAN | CLOBAZAM | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET | |||||||||
126082971 | 12608297 | 31 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126082971 | 12608297 | 1 | Anaplastic astrocytoma |
126082971 | 12608297 | 24 | Antifungal prophylaxis |
126082971 | 12608297 | 25 | Prophylaxis |
126082971 | 12608297 | 26 | Prophylaxis |
126082971 | 12608297 | 27 | Prophylaxis |
126082971 | 12608297 | 28 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126082971 | 12608297 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126082971 | 12608297 | Hyperkalaemia | |
126082971 | 12608297 | Leukopenia | |
126082971 | 12608297 | Lymphocyte count decreased | |
126082971 | 12608297 | Monocyte count increased | |
126082971 | 12608297 | Neutropenia | |
126082971 | 12608297 | Neutrophil count decreased | |
126082971 | 12608297 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126082971 | 12608297 | 1 | 20111019 | 20111026 | 0 | |
126082971 | 12608297 | 2 | 20111109 | 20111119 | 0 | |
126082971 | 12608297 | 3 | 20120121 | 20120125 | 0 | |
126082971 | 12608297 | 4 | 20120224 | 20120228 | 0 | |
126082971 | 12608297 | 5 | 20120324 | 20120328 | 0 | |
126082971 | 12608297 | 6 | 20120424 | 20120428 | 0 | |
126082971 | 12608297 | 7 | 20120524 | 20120528 | 0 | |
126082971 | 12608297 | 8 | 20120615 | 20120619 | 0 | |
126082971 | 12608297 | 9 | 20120715 | 20120719 | 0 | |
126082971 | 12608297 | 10 | 20120815 | 20120819 | 0 | |
126082971 | 12608297 | 11 | 20120915 | 20120919 | 0 | |
126082971 | 12608297 | 12 | 20121115 | 20121119 | 0 | |
126082971 | 12608297 | 13 | 20121215 | 20121219 | 0 | |
126082971 | 12608297 | 14 | 20130126 | 20130130 | 0 | |
126082971 | 12608297 | 15 | 20130405 | 20130409 | 0 | |
126082971 | 12608297 | 16 | 20130510 | 20130514 | 0 | |
126082971 | 12608297 | 17 | 20130621 | 20130625 | 0 | |
126082971 | 12608297 | 18 | 20130719 | 20130723 | 0 | |
126082971 | 12608297 | 19 | 20130816 | 20130820 | 0 | |
126082971 | 12608297 | 20 | 20130913 | 20130917 | 0 | |
126082971 | 12608297 | 21 | 20131018 | 20131022 | 0 | |
126082971 | 12608297 | 22 | 20110920 | 20111101 | 0 | |
126082971 | 12608297 | 23 | 20111101 | 0 | ||
126082971 | 12608297 | 24 | 20111019 | 20111124 | 0 | |
126082971 | 12608297 | 25 | 20111019 | 20111129 | 0 | |
126082971 | 12608297 | 26 | 20111019 | 20111023 | 0 | |
126082971 | 12608297 | 27 | 20111019 | 20111023 | 0 | |
126082971 | 12608297 | 28 | 20111019 | 20111020 | 0 | |
126082971 | 12608297 | 29 | 20111124 | 0 | ||
126082971 | 12608297 | 30 | 20110113 | 20140904 | 0 |